Detalhe da pesquisa
1.
Preclinical Models of Anal Cancer Combined-Modality Therapy.
J Surg Res
; 294: 82-92, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37864962
2.
The Use of the Protease Inhibitor, Saquinavir, to Treat Anal Cancer Spheroids Derived From Human Papillomavirus Transgenic Mice.
Dis Colon Rectum
; 66(3): 360-365, 2023 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36599112
3.
Anal Cancer Prevention Through the Topical Use of Single or Dual PI3K/mTOR Inhibitors.
J Surg Res
; 282: 137-146, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36274448
4.
PI3K/mTOR inhibition prevents anal cancer in mice with established low-grade anal dysplasia.
Exp Mol Pathol
; 125: 104752, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35183509
5.
Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
Viruses
; 15(4)2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37112993
6.
Systemic Delivery of a Dual PI3K/mTOR Inhibitor More Effective than Topical Delivery in Preventing Anal Carcinogenesis in an HPV Transgenic Mouse Model.
J Cancer Sci Clin Ther
; 6(2): 157-173, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36683775
7.
The use of a topical protease inhibitor, Saquinavir, to alleviate mouse papillomavirus-mediated anal disease.
Virology
; 576: 96-104, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36206607
8.
Efficacy of Topically Administered Dihydroartemisinin in Treating Papillomavirus-Induced Anogenital Dysplasia in Preclinical Mouse Models.
Viruses
; 14(8)2022 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35893697
9.
Obesity Augments Glucocorticoid-Dependent Muscle Atrophy in Male C57BL/6J Mice.
Biomedicines
; 8(10)2020 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33076257